Arcus Share Price

Arcus Share Price

NYSE: RCUS | Small Cap | Healthcare
$15.78
-$0.63 (-3.87%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Arcus Stock Performance

Open
$16.48
Prev. Close
$16.41
Circuit Range
N/A
Day Range
$15.78 - $16.71
Year Range
$15.78 - $31.68
Volume
63,103
Average Traded
$16.02

Arcus Share Price Today

As of 19 November 2026, Arcus Biosciences, Inc.'s share price is $15.78. The stock opened at $16.48, compared to its previous close of $16.41. During today's trading session, Arcus Biosciences, Inc.'s share price traded between $15.78 and $16.71, with an average price of $16.25. Over the past 52 weeks, the stock has recorded a high of $31.68 and a low of $15.78. In terms of performance, Arcus Biosciences, Inc.'s share price has declined by 37.86% over the last six months and is down 39.57% on a year-on-year basis.

Arcus Share Price Chart

Line chart of the Arcus price trend over the selected period. The price fell overall, ranging from 15.78 to 16.70, ending at 15.78.
$15.78$16.71
L
Show Current Price
H

Arcus Stock Fundamentals & Key Indicators

Market Cap
$1.69B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.15
Revenue (TTM)
$247.00B
Return On Equity (TTM)
-126.54%
Profit Margin
-142.91%
Debt to Equity
0.28
Quarterly Earnings Growth YoY
-20.75%

Arcus Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$33.00$17.00$41.00$9.00
Net Profit-$106.00-$128.00-$91.00-$128.00
Net Profit Margin-321.21%-752.94%-221.95%-1422.22%
Income ChangeN/A-20.75%28.91%-40.66%

Arcus Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$112.00$117.00$258.00$247.00
Net Profit-$267.00-$307.00-$283.00-$353.00
Net Profit Margin-238.39%-262.39%-109.69%-142.91%
Income ChangeN/A-14.98%7.82%-24.73%

Arcus Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets132.0134.0264.0278.0
Current Assets1007.01016.0831.01067.0
Total Assets1139.01150.01095.01345.0
Non Current Liabilities277.0439.0449.0495.0
Current Liabilities231.0226.0184.0193.0
Total Liabilities508.0665.0633.0688.0
Shareholders' Equity631.0485.0462.0657.0

Arcus Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-482.0-170.0-306.0438.0
Investing66.0-84.0194.0-413.0
Financing488.0277.033.033.0

About Arcus

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Arcus Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$18.40
$15.78
-13.28%
Oct 2026
$25.75
$18.19
-29.77%
Sep 2026
$29.41
$25.90
-15.36%
Aug 2026
$27.70
$30.60
+8.32%
Jul 2026
$30.91
$28.25
-8.32%
Jun 2026
$25.21
$30.82
+21.39%
May 2026
$25.41
$25.39
-0.53%
Apr 2026
$21.95
$25.52
+18.04%
Mar 2026
$20.39
$21.62
+6.03%
Feb 2026
$21.07
$20.39
-3.07%
Jan 2026
$23.55
$21.04
-11.73%
Dec 2025
$25.68
$23.83
-8.71%

Arcus Share Price FAQs